In addition, we observed that loss of Frmd8 significantly decreased the expression of Esr1 and Pgr in normal cells of mammary tumors and decreased expression of Frmd8 in tumor cells accompanied with low expression of Esr1 and Pgr compared with normal cells (Figure 2L, Figure 2—figure supplement 1E). This evidence concerns the gene ESR1 and breast cancer.